What's new

Orphan designation: Seladelpar Treatment of primary biliary cholangitis, 20/02/2025 Positive

Orphan designation: Seladelpar Treatment of primary biliary cholangitis, 20/02/2025 Positive

Mar 12, 2025 - 17:06
 0
Orphan designation: Seladelpar Treatment of primary biliary cholangitis, 20/02/2025 Positive
Orphan designation: Seladelpar Treatment of primary biliary cholangitis, 20/02/2025 Positive
Read More

Tags:

Previous Article

Orphan designation: pelabresib monohydrate Treatment of myelofibrosis, 17/02/202...

Next Article

Orphan designation: Magrolimab Treatment of myelodysplastic syndromes, 26/06/202...

Related Posts

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – June 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 26 June 2025, 10:00 (CEST) to 26 June 2025, 12:00 (CEST)

Meeting of the Executive Steering Group on Shortages an...

Feb 9, 2025  0

List of withdrawn medicinal products in accordance with...

Mar 7, 2025  0

Human medicines European public assessment report (EPAR): Obodence, denosumab, Date of authorisation: 12/02/2025, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025  0